- Home
- ONC vs WRB Comparison
ONC vs WRB Comparison
Compare ONC & WRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONC | WRB |
|---|---|---|
| Founded | 2010 | 1967 |
| Country | Switzerland | United States |
| Employees | 12000 | 8804 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 25.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONC | WRB |
|---|---|---|
| Price | $309.60 | $65.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 15 |
| Target Price | ★ $374.75 | $68.71 |
| AVG Volume (30 Days) | 187.3K | ★ 1.8M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $747.23 | $5.24 |
| Revenue Next Year | $15.78 | $4.97 |
| P/E Ratio | $614.06 | ★ $15.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $227.40 | $63.68 |
| 52 Week High | $385.22 | $78.96 |
Technical Indicators
Market Signals| Indicator | ONC | WRB |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 41.92 |
| Support Level | $307.93 | $65.21 |
| Resistance Level | $320.35 | $73.41 |
| Average True Range (ATR) | 7.68 | 1.21 |
| MACD | 4.77 | 0.22 |
| Stochastic Oscillator | 82.89 | 47.34 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About WRB W.R. Berkley Corporation
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.